Ranu H S
Biomed Mater Eng. 1998;8(2):111-8.
This symposium identified the major challenges in biomedical research that will benefit from bioengineering applications. Attention was focused on the important role that bioengineers will play in future advances in biomedical research. There was considerable discussion about how to integrate bioengineering with biological research in meeting the challenges of the twenty-first century. Symposium presenters showcased the accomplishments of NIH-funded bioengineering researches and increased the visibility of bioengineering to NIH leaders, staff and members of the intramural and extramural research community. Recommendations were also made for future NIH-funded research projects. Attention was also placed on how basic bioengineering research can lead to commercialization of new health care technology and therefore maintain the Nation's leadership in this important area. New products, from biotechnology and novel devices for diagnosis and treatment, are marketed through interactions between universities, medical centers, small start-up firms, and larger, more established companies. In the United States the gross revenue of the bioengineering private sector industry involved in the manufacture of health care products already exceeds $40 billion. More than 750 persons attended this bioengineering symposium. Over 110 scientific posters and exhibits relating to biology and medicine were presented. They provided a forum for showcasing NIH-funded bioengineering projects and fostered future collaboration among academic investigators, industry and members of the small business community. The role of bioengineering in the 21st century has already been highlighted by the author as far as research, education and space age technologies are concerned. The contributions of Pugwash bioengineer, Maciej Natecz, a member of the Polish Academy of Sciences, was recognized by the Conference Planning Committee. He was honoured for his work in nuclear disarmament.
本次研讨会确定了生物医学研究中的重大挑战，这些挑战将受益于生物工程应用。会议重点关注了生物工程师在生物医学研究未来进展中将发挥的重要作用。关于如何将生物工程与生物学研究相结合以应对21世纪的挑战，进行了大量讨论。研讨会的演讲者展示了美国国立卫生研究院（NIH）资助的生物工程研究成果，并提高了生物工程在NIH领导、工作人员以及内部和外部研究社区成员中的知名度。会议还针对未来NIH资助的研究项目提出了建议。同时也关注了基础生物工程研究如何能够推动新医疗技术的商业化，从而保持美国在这一重要领域的领先地位。新产品，包括生物技术产品以及用于诊断和治疗的新型设备，通过大学、医疗中心、小型初创公司和规模更大、更成熟的公司之间的互动进行销售。在美国，参与医疗保健产品制造的生物工程私营行业总收入已超过400亿美元。超过750人参加了此次生物工程研讨会。会上展示了110多份与生物学和医学相关的科学海报和展品。它们为展示NIH资助的生物工程项目提供了一个平台，并促进了学术研究人员、行业和小企业社区成员之间未来的合作。就研究、教育和太空时代技术而言，作者已经强调了生物工程在21世纪的作用。波兰科学院院士、帕格沃什生物工程师马切伊·纳泰茨的贡献得到了会议策划委员会的认可。他因在核裁军方面的工作而受到表彰。
